45 studies found for:    " January 13, 2013":" February 12, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" January 13, 2013":" February 12, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Not yet recruiting DRV/r + RPV QD: Efficacy and Toxicity Reduction
Condition: HIV-positive Subjects With HIV-RNA <50 Copies/mL
Interventions: Drug: RPV + DRV/r;   Drug: subjects will continue the PI/r-containing regimen that is on-going at the time of enrollment.
2 Active, not recruiting Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults
Conditions: HIV;   HIV Infections
Interventions: Drug: E/C/F/TAF;   Drug: E/C/F/TDF;   Drug: Placebo to match E/C/F/TDF;   Drug: Placebo to match E/C/F/TAF
3 Active, not recruiting Clinic-based ART Diagnostic Evaluation
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infection;   RNA Virus Infections;   Virus Diseases
Intervention: Other: HIV-1 viral load testing
4 Not yet recruiting Steady State PK in Malnourished HIV Infected Children
Conditions: HIV Positive;   Malnourished
Intervention: Drug: ZDV+3TC+LPV/r
5 Not yet recruiting Enhanced Access to HIV Care for Drug Users in San Juan, Puerto Rico
Conditions: HIV;   AIDS;   Substance Abuse
Interventions: Behavioral: Enhanced HIV Care Access and Retention Intervention;   Behavioral: HIV Testing Campaign;   Behavioral: Treatment Re-engagement Campaign;   Behavioral: Patient Navigator Linkage to Care and Substance Abuse Treatment Team;   Behavioral: Mobile Care Clinic
6 Recruiting Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With Stage II-IV HIV-Associated Hodgkin Lymphoma
Conditions: HIV Infection;   HIV-associated Hodgkin Lymphoma;   Stage II Adult Hodgkin Lymphoma;   Stage III Adult Hodgkin Lymphoma;   Stage IV Adult Hodgkin Lymphoma
Interventions: Drug: doxorubicin hydrochloride;   Drug: vinblastine;   Drug: dacarbazine;   Drug: brentuximab vedotin;   Other: pharmacological study;   Other: laboratory biomarker analysis
7 Active, not recruiting Renal, Endocrine, and Bone Changes in Response to FTC/TDF in Uninfected Young Men Who Have Sex With Men (YMSM).
Condition: HIV Infection
Intervention: Drug: FTC/TDF (Truvada®)
8 Recruiting An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM)
Condition: HIV Infection
Interventions: Behavioral: 3MV;   Behavioral: PCC;   Drug: Emtricitabine/tenofovir (FTC/TDF (Truvada®))
9 Recruiting Adherence Support Intervention for Persons Living With HIV/AIDS (PLWHA) on Antiretroviral Therapy (ART) in Estonia
Conditions: HIV;   AIDS;   Medication Adherence
Intervention: Behavioral: Situated Optimal Adherence Intervention
10 Not yet recruiting Living Well Project
Condition: Acquired Immunodeficiency Syndrome (AIDS)
Interventions: Behavioral: AIDS EPC Package plus MI;   Other: Standard of Care (SOC)
11 Recruiting A Demonstration Project to Add Pre- or Post-exposure Prophylaxis to Combination HIV Prevention Services
Condition: HIV Prevention
Intervention: Drug: emtricitabine 200mg/tenofovir 300mg
12 Not yet recruiting Music for Health Project
Condition: Human Immunodeficiency Virus
Intervention: Behavioral: mobile phone application
13 Not yet recruiting Pilot Study of Bydureon to Treat Diabetes in HIV-infected Adults
Conditions: Human Immunodeficiency Virus Infection;   Diabetes Mellitus
Intervention: Drug: extended-release exenatide
14 Active, not recruiting An Expanded Access Protocol for Subjects Who Have Completed Clinical Studies Involving Maraviroc
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: Continued Access Arm
15 Recruiting Switching Undetectables to Selzentry
Conditions: Human Immunodeficiency Virus;   AIDS
Intervention: Drug: Maraviroc
16 Recruiting Safety and Pharmacokinetics of Raltegravir in HIV-1-Exposed Newborn Infants at High Risk of Acquiring HIV-1 Infection
Condition: HIV Infections
Intervention: Drug: Raltegravir
17 Completed Feasibility of Using a Structured Daily Diary
Condition: HIV Infection
Intervention: Behavioral: Structured daily diary
18 Active, not recruiting Evaluating the Safety and Immune Response to Three HIV Vaccine Schedules in Healthy, HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: DNA-HIV-PT123 vaccine;   Biological: NYVAC-HIV-PT1 vaccine;   Biological: NYVAC-HIV-PT4 vaccine;   Biological: Placebo for DNA-HIV-PT123 vaccine;   Biological: Placebo for NYVAC-HIV-PT1 vaccine;   Biological: Placebo for NYVAC-HIV-PT4 vaccine
19 Not yet recruiting Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin Lymphoma
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma;   AIDS-related Diffuse Large Cell Lymphoma;   AIDS-related Diffuse Mixed Cell Lymphoma;   AIDS-related Diffuse Small Cleaved Cell Lymphoma;   AIDS-related Immunoblastic Large Cell Lymphoma;   AIDS-related Lymphoblastic Lymphoma;   AIDS-related Peripheral/Systemic Lymphoma;   AIDS-related Small Noncleaved Cell Lymphoma;   Anaplastic Large Cell Lymphoma;   Angioimmunoblastic T-cell Lymphoma;   Cutaneous B-cell Non-Hodgkin Lymphoma;   Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue;   Hepatosplenic T-cell Lymphoma;   HIV-associated Hodgkin Lymphoma;   Intraocular Lymphoma;   Nodal Marginal Zone B-cell Lymphoma;   Noncutaneous Extranodal Lymphoma;   Peripheral T-cell Lymphoma;   Recurrent Adult Burkitt Lymphoma;   Recurrent Adult Diffuse Large Cell Lymphoma;   Recurrent Adult Diffuse Mixed Cell Lymphoma;   Recurrent Adult Diffuse Small Cleaved Cell Lymphoma;   Recurrent Adult Grade III Lymphomatoid Granulomatosis;   Recurrent Adult Hodgkin Lymphoma;   Recurrent Adult Immunoblastic Large Cell Lymphoma;   Recurrent Adult Lymphoblastic Lymphoma;   Recurrent Adult T-cell Leukemia/Lymphoma;   Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma;   Recurrent Grade 1 Follicular Lymphoma;   Recurrent Grade 2 Follicular Lymphoma;   Recurrent Grade 3 Follicular Lymphoma;   Recurrent Mantle Cell Lymphoma;   Recurrent Marginal Zone Lymphoma;   Recurrent Mycosis Fungoides/Sezary Syndrome;   Recurrent Small Lymphocytic Lymphoma;   Refractory Hairy Cell Leukemia;   Small Intestine Lymphoma;   Splenic Marginal Zone Lymphoma;   Stage I AIDS-related Lymphoma;   Stage II AIDS-related Lymphoma;   Stage III AIDS-related Lymphoma;   Stage IV AIDS-related Lymphoma;   T-cell Large Granular Lymphocyte Leukemia;   Testicular Lymphoma;   Waldenström Macroglobulinemia
Interventions: Drug: carmustine;   Drug: cytarabine;   Drug: melphalan;   Drug: etoposide;   Drug: O6-benzylguanine;   Procedure: autologous hematopoietic stem cell transplantation;   Procedure: peripheral blood stem cell transplantation;   Other: laboratory biomarker analysis
20 Completed Nevirapine vs Ritonavir-boosted Lopinavir in ART Naive HIV-infected Adults in a Resource Limited Setting
Condition: HIV-1 Infection
Interventions: Drug: nevirapine;   Drug: ritonavir-boosted Lopinavir;   Drug: Tenofovir/emtricitabine;   Drug: Zidovudine/lamivudine

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years